CD271+ stromal cells expand in arthritic synovium and exhibit a proinflammatory phenotype
Open Access
- 15 March 2016
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 1-8
Abstract
CD271+ stromal cells (SCs) with multipotent stem cell capacity have been identified in synovial tissues, but their functional significance is unknown. We analyzed the distribution of CD271+ cells in inflammatory synovial tissues as well as their ex vivo immunomodulatory and inflammatory phenotypes. CD271 expression was analyzed by immunohistochemistry in synovial tissues and by flow cytometry in primary adherent synovial cell cultures from rheumatoid arthritis (RA), osteoarthritis (OA), and non-inflammatory control tissues. Isolation of CD271+ synovial SCs was carried out by magnetic cell sorting. Allogeneic T-cell/SC cocultures were performed to analyze the regulatory capacity of these cells on T-cell proliferation and cytokine production. The production of inflammatory mediators was analyzed in cultures of sorted CD271+/− SCs. The capacity of CD271+/− SCs to induce inflammatory cell recruitment in vivo was evaluated in subcutaneous implants in immunodeficient mice. CD271+ SC were detected in non-inflammatory as well as in arthritic synovial tissues with a specific perivascular distribution. CD271+ SC density was increased in RA and OA compared with normal synovial tissues. T-cell proliferation and cytokine synthesis were similarly modified by CD271+ and CD271− SCs. Sorted CD271+ SCs from OA synovial tissues released significantly more interleukin (IL)-6, matrix metalloproteinase (MMP)-1, and MMP-3 than CD271− SCs. In immunodeficient mice, implants of CD271+ SCs induced significantly higher myeloid cell infiltration than CD271− SCs. Our results demonstrate that CD271+ perivascular SCs expand in RA and OA synovial tissues. CD271+ cells showed enhanced proinflammatory properties ex vivo and in vivo, whereas immunoregulatory properties were equivalent in CD271+ and CD271− SC.Keywords
Funding Information
- FEDER-Instituto de Salud Carlos III (FIS12/439, RETICS RD12/009 RIER, Río Hortega program, Miguel Servet program)
- Comunidad de Madrid (RAPHYME-CM S2010/BMD2350)
This publication has 29 references indexed in Scilit:
- The immunomodulatory capacity of mesenchymal stem cellsTrends in Molecular Medicine, 2012
- Bone Marrow Cells Immunomagnetically Selected For CD271+ Antigen Promote In Vitro the Repair of Articular Cartilage DefectsTissue Engineering Part A, 2011
- In vivo microfocal computed tomography and micro–magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the ratArthritis & Rheumatism, 2010
- Large‐scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: Implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cellsArthritis & Rheumatism, 2010
- Flow cytometric characterization of freshly isolated and culture expanded human synovial cell populations in patients with chronic arthritisArthritis Research & Therapy, 2010
- Cadherin-11 Induces Rheumatoid Arthritis Fibroblast-Like Synoviocytes to Form Lining Layers in VitroThe American Journal of Pathology, 2006
- Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endotheliumFEBS Letters, 2005
- A stromal address code defined by fibroblastsTrends in Immunology, 2005
- Defining a role for fibroblasts in the persistence of chronic inflammatory joint diseaseAnnals of the Rheumatic Diseases, 2004
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988